GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Cyclically Adjusted PS Ratio

Medrx Co (TSE:4586) Cyclically Adjusted PS Ratio : (As of Jun. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medrx Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Medrx Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co Cyclically Adjusted PS Ratio Chart

Medrx Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 10.79 19.74

Medrx Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.22 - 20.21 19.74 -

Competitive Comparison of Medrx Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medrx Co's Cyclically Adjusted PS Ratio falls into.



Medrx Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medrx Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medrx Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/107.2000*107.2000
=0.000

Current CPI (Mar. 2024) = 107.2000.

Medrx Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.898 98.000 3.170
201409 0.526 98.500 0.572
201412 0.134 97.900 0.147
201503 2.103 97.900 2.303
201506 0.171 98.400 0.186
201509 2.973 98.500 3.236
201512 0.364 98.100 0.398
201603 1.388 97.900 1.520
201606 0.070 98.100 0.076
201609 1.378 98.000 1.507
201612 0.019 98.400 0.021
201703 2.120 98.100 2.317
201706 0.087 98.500 0.095
201709 0.091 98.800 0.099
201712 20.095 99.400 21.672
201803 0.026 99.200 0.028
201806 0.799 99.200 0.863
201809 0.000 99.900 0.000
201812 0.000 99.700 0.000
201903 1.801 99.700 1.936
201906 0.802 99.800 0.861
201909 10.947 100.100 11.723
201912 0.119 100.500 0.127
202003 0.000 100.300 0.000
202006 0.951 99.900 1.020
202009 0.000 99.900 0.000
202012 5.145 99.300 5.554
202103 0.381 99.900 0.409
202106 0.000 99.500 0.000
202109 0.037 100.100 0.040
202112 0.001 100.100 0.001
202203 0.080 101.100 0.085
202206 0.305 101.800 0.321
202209 0.000 103.100 0.000
202212 1.772 104.100 1.825
202303 0.230 104.400 0.236
202306 0.000 105.200 0.000
202309 0.582 106.200 0.587
202312 0.007 106.800 0.007
202403 0.000 107.200 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medrx Co  (TSE:4586) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medrx Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Medrx Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medrx Co (TSE:4586) Business Description

Traded in Other Exchanges
N/A
Address
431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines